The Chemours Company has grown revenue −2.9% a year over three years and 0.47% a year over five. Revenue growth, 3-year annual rate: −2.9% (Specialty Chemicals median +3.3%). Revenue growth, 5-year rate: +0.47%, growth has slowed since the five-year average. Years of annual history on file: 13, FY2013 to FY2025, as filed.

CCThe Chemours Company

Basic Materials

$13.61-19% 1Y

$13.61

$10.3952 weeks$27.84

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though operating margin narrowing (−1.0 points).

1 to watch, 1 neutral, 1 without data

Revenue trend−1% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +0% a year.

Margin direction−1.0 points operating

Trailing-twelve-month operating margin, -1.6% now against -0.6% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbehind 89% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is CC growing?

The Chemours Company has grown revenue −2.9% a year over three years and 0.47% a year over five.

−2.9%

Revenue growth, 3-year annual rate · Specialty Chemicals median +3.3% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +0.47%
Revenue growth, 5-year rate · −2.9% over three · growth has slowed since the five-year average
Years of annual history on file: 13
Years of annual history on file · FY2013 to FY2025, as filed

Details›